214610.Kq
The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.
Business. The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 17,942,439,830, which significantly exceeds its total liabilities of KRW 9,420,994,410, resulting in a current ratio of 2.83. The price-to-book ratio of 1.2 and a debt-to-equity ratio of 0.43 indicate a relatively conservative capital structure, with limited leverage and a solid equity base.
Profitability metrics, however, are negative, with a return on equity of -1.0977 and a return on assets of -0.69, reflecting a challenging operating environment. The company reported a net loss of KRW 17,500,196,130 and an operating loss of KRW 12,006,628,070, which are significantly below the industry median for profitability metrics.
The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no geographic diversification provided in the available data. This lack of segment and geographic diversification may increase exposure to sector-specific risks.
Looking ahead, the company is expected to face continued financial pressure, with no positive revenue growth projected in the current or next fiscal year. The operating cash flow of -KRW 10,099,915,010 and free cash flow of -KRW 25,088,290,490 indicate a cash outflow, which could limit reinvestment and growth opportunities.
Risk factors include the company's negative net income and operating income, which may impact its ability to service debt or fund operations without external financing. The risk assessment indicates low dilution and liquidity risk, with no immediate filing-based flags detected. However, the negative free cash flow and capital expenditure of -KRW 8,571,686,360 suggest potential future financing needs.
Recent filings and transcripts have not disclosed any material events or strategic shifts that would significantly alter the company's financial trajectory. The company's financial performance remains consistent with its recent history, with no notable improvements in profitability or cash flow generation.
- The company has a strong liquidity position with a current ratio of 2.83 and significant cash reserves.
- Profitability is negative, with a return on equity of -1.0977 and a return on assets of -0.69.
- The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company is expected to continue facing financial pressure with no positive revenue growth projected.
- Risk factors include negative net income and operating income, which may impact the company's ability to service debt or fund operations.
- No immediate liquidity or dilution risks were detected, but the negative free cash flow and capital expenditure suggest potential future financing needs.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 214610.KQ Market data — financials · 2026-05-26